menu search

Cellectar Biosciences Expands Global Intellectual Property Portfolio with Four Patent Grants

Cellectar Biosciences Expands Global Intellectual Property Portfolio with Four Patent Grants
FLORHAM PARK, N.J., Oct. 02, 2023 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, today announced significant advancements to its global intellectual property (IP) portfolio. Cellectar has secured four patents across the key global regions […] The post Cellectar Biosciences Expands Global Intellectual Property Portfolio with Fou... Read More
Posted: Oct 2 2023, 10:35
Author Name: forextv
Views: 082929

Search within

Pages Search Results: